טוען...
Targeting metabolic vulnerabilities of cancer: Small molecule inhibitors in clinic
BACKGROUND: Altered cell metabolism is an established hallmark of cancer. Advancement in our understanding of dysregulated cellular metabolism has aided drastically in identifying metabolic vulnerabilities that can be exploited therapeutically. Indeed, this knowledge has led to the development of a...
שמור ב:
| הוצא לאור ב: | Cancer Rep (Hoboken) |
|---|---|
| Main Authors: | , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
John Wiley and Sons Inc.
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7941539/ https://ncbi.nlm.nih.gov/pubmed/32721114 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cnr2.1131 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|